Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(5)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05552521Completed

Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants

Role: collaborator

NCT05070637Not ApplicableCompleted

Circulating Tumor Cell Reducing No-touch Nephrectomy

Role: collaborator

NCT02333175Not ApplicableCompleted

Care for Late Stage Parkinsonism

Role: collaborator

NCT03578614Not ApplicableCompleted

Impact of Physical Activity in Vascular Cognitive Impairment ( AFIVASC )

Role: lead

NCT02065713Phase 3Completed

Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

Role: lead

NCT02385019Phase 1Unknown

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Role: lead

NCT02753192Not ApplicableUnknown

Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison

Role: collaborator

NCT01417455Completed

Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis

Role: lead

NCT02280538Not ApplicableUnknown

Trial to Assess the Structural Effect and Long-term Symptomatic Relief of Intra-articular Injections of Hyaluronic Acid in Primary Knee OA

Role: collaborator

All 9 trials loaded